VEGFC and lymphatic system disorder: The precise mechanism of action of propranolol in lymphatic disease remains to be determined, but studies suggest that propranolol exerts its effect through the reduction of VEGF expression and by reducing circulating pro-lymphangiogenic factors such as VEGF-C [34].